与1型糖尿病相关的痛苦:目前对护理的影响
Alba Rodríguez-Muñoz1, María José Picón-César2, Francisco J Tinahones3
1Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Málaga, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma Bionand, Málaga, Spain.
European journal of internal medicine
|April 12, 2024
概括
1型糖尿病 (T1D) 的痛苦是一个重要的情绪负担,影响血糖控制和心理健康. 新的干预措施和技术正在出现,以管理T1D患者的这种被忽视的疾病.
科学领域:
- 内分泌学 在内分泌学.
- 心理学 心理学 心理学
- 公共卫生 公共卫生
背景情况:
- 1型糖尿病 (T1D) 呈现出复杂的慢性挑战,具有重大的健康和心理社会影响.
- 与T1D相关的痛苦 (DD) 是与生活T1D相关的特定情绪负担,经常被忽视,但普遍存在.
- DD显著影响T1D患者的血糖控制和心理健康.
研究的目的:
- 总结有关T1D相关痛苦的当前知识.
- 讨论目前DD的诊断和管理方法.
- 探索解决DD的未来前景和技术进步.
主要方法:
- 关于与T1D相关的痛苦的文献综述.
- 对诊断标准的分析,区分DD和精神健康障碍.
- 对DD的现有和新兴干预策略的审查.
主要成果:
- 精神疾病是一个独特的临床实体,需要特定的诊断方法,尽管症状与其他心理健康状况重叠.
- 行为,心理社会和技术干预措施在管理DD方面表现有前途.
- 有效的DD管理对于改善T1D患者的整体福祉至关重要.
结论:
- 与T1D相关的痛苦是慢性疾病管理的关键方面,需要有针对性的关注.
- 为了有效地管理DD,需要采用多方面的方法,包括新的干预措施和技术.
- 进一步的研究和基于证据的战略的实施对于减轻T1D人口中DD的负担至关重要.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Management and Pharmacotherapy
275
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
275
Diabetes: Symptoms, Diagnosis, and Complications
528
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
528
Psychoneuroimmunology: Diabetes and Cancer
28
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
28
Insulin: Dosing Regimen and Adverse Effects
169
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
169


